Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The molecule was developed by Frank Ng's group at Monash University and Metabolic Pharmaceuticals in Australia during the 1990s and 2000s as a potential anti-obesity drug intended to isolate the lipolytic region of hGH without activating the growth hormone receptor or raising IGF-1.nnIn published preclinical work, the fragment has been shown to stimulate lipolysis, suppress lipogenesis, and modulate the beta-3 adrenergic receptor pathway in adipose tissue rather than acting through the classical hGH receptor
The benefits of Tricare insurance coverage are access to quality healthcare, affordability, and flexibility in choosing healthcare providers
Specification shown may be different from actual products
G.InceC
Always confirm the peptide milligram content from the vial label clearly
US$ 26.18
US$ 28.03
US$ 20.41
US$ 24.18
US$ 21.27
